Effect of Baduanjin on cardiopulmonary function in patients with stage 3-5 chronic kidney disease: a randomized controlled study
- Conditions
- Chronic Kidney Disease
- Registration Number
- ITMCTR2200006004
- Lead Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
? Patients who met the diagnostic criteria for CKD and were CKD3-5 without dialysis.
? Patients aged 18-75 years.
? Patients with independent movement ability and able to complete baduanjin movement.
? Informed consent.
? If the following conditions need emergency treatment, the patient shall be excluded: HGB < 70g/L; Or carbon dioxide binding force < 13mmol/L; Or blood potassium > 5.5mmol/L.
? Pregnant or lactating women.
? Complicated with active malignant tumor, decompensated liver cirrhosis, gastrointestinal bleeding, hematopoietic system serious primary diseases; Patients with serious heart and lung diseases, such as acute myocardial infarction, unstable angina pectoris, acute pulmonary embolism or pulmonary infarction; Severe hypertension (systolic blood pressure =200mmHg, diastolic blood pressure =120mmHg) and difficult to control blood pressure; Severe vasculitis of lower extremities, deep venous thrombosis of lower extremities; Patients with muscle, bone, joint and other motor system lesions who cannot or should not exercise.
? Patients with severe mental and cognitive disorders.
? Patients are participating in other researches.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method peak oxygen uptake,PeakVO2;
- Secondary Outcome Measures
Name Time Method Indicators of body function and nutritional status;Indicators of body function and nutritional status;Quality of Life;The quality of sleep;Indicators of body function and nutritional status;